Abstract |
The prognosis for patients with Philadelphia-negative myeloproliferative neoplasms (MPN) who evolve into acute myeloid leukemia (AML) or blast phase (MPN-BP) is extremely poor. Although allogeneic stem cell transplantation (allo-SCT) is considered potentially curative, very few patients have been reported who have undergone allo-SCT for MPN-BP; therefore the success rate remains unknown. In a retrospective review, we identified 13 patients with an MPN transformation to blast phase after a median 9 years (range 5 months to 30 years); 8 (median age 55) continued to allo-SCT within 6 months. Induction chemotherapy cleared blood/marrow blasts in 60% (6/10) (2 declined therapy, 1 had early death). At the time of allo-SCT, 5/8 patients were in complete remission (CR) of their leukemia or had returned to MPN chronic phase (CP), 2 had residual blood blasts and 1 was refractory with >5% marrow blasts. At follow-up (median 20.3 months), 6 patients are alive in CR of both their leukemia/MPN. All 5 patients in CR/CP at pre-allo-SCT remain alive in remission, while 2/3 with persistent blood/marrow blasts relapsed and expired. We conclude that MPN-BP can be cured by allo-SCT in a significant percentage of patients, but that adequate leukemic clearance prior to allo-SCT offers an optimal outcome.
|
Authors | Chad Cherington, James L Slack, Jose Leis, Roberta H Adams, Craig B Reeder, Joseph R Mikhael, John Camoriano, Pierre Noel, Veena Fauble, Jeffrey Betcher, Meagan S Higgins, Ginger Gillette-Kent, Lisa D Tremblay, Mary E Peterson, Jane J Olsen, Raoul Tibes, Ruben A Mesa |
Journal | Leukemia research
(Leuk Res)
Vol. 36
Issue 9
Pg. 1147-51
(Sep 2012)
ISSN: 1873-5835 [Electronic] England |
PMID | 22578777
(Publication Type: Evaluation Study, Journal Article)
|
Copyright | Copyright © 2012 Elsevier Ltd. All rights reserved. |
Topics |
- Adult
- Aged
- Blast Crisis
(therapy)
- Female
- Follow-Up Studies
- Hematologic Neoplasms
(diagnosis, genetics, pathology, therapy)
- Humans
- Male
- Middle Aged
- Myeloproliferative Disorders
(diagnosis, genetics, pathology, therapy)
- Remission Induction
- Retrospective Studies
- Stem Cell Transplantation
(methods)
- Transplantation, Homologous
- Treatment Outcome
|